Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Weissman

Showing results (381-390 of 408) with videos related to

Pageof 41
Sort By:
The Journal of Pathology|April 27, 2017
The histone methyltransferase EZH2 is a therapeutic target in small cell carcinoma of the ovary, hypercalcaemic typeYemin Wang, Shary Yuting Chen, Anthony N Karnezis, et al.
Genomics|May 8, 1998
Divergently transcribed overlapping genes expressed in liver and kidney and located in the 11p15.5 imprinted domainP R Cooper, N J Smilinich, C D Day, et al.
Oncogene|May 16, 2022
TP53, CDKN2A/P16, and NFE2L2/NRF2 regulate the incidence of pure- and combined-small cell lung cancer in miceSamera H Hamad, Stephanie A Montgomery, Jeremy M Simon, et al.
Oncogene|August 24, 2022
Correction: TP53, CDKN2A/P16, and NFE2L2/NRF2 regulate the incidence of pure- and combined-small cell lung cancer in miceSamera H Hamad, Stephanie A Montgomery, Jeremy M Simon, et al.
Journal of the American Medical Informatics Association : JAMIA|November 18, 2021
Development and validation of a prediction model for actionable aspects of frailty in the text of clinicians' encounter notesJacob A Martin, Andrew Crane-Droesch, Folasade C Lapite, et al.
The Journal of Pathology|July 4, 2020
A conditional mouse expressing an activating mutation in NRF2 displays hyperplasia of the upper gastrointestinal tract and decreased white adipose tissueBrittany M Bowman, Stephanie A Montgomery, Travis P Schrank, et al.
Genomics|November 5, 1997
Functional characterization of human nucleosome assembly protein-2 (NAP1L4) suggests a role as a histone chaperoneP Rodriguez, D Munroe, D Prawitt, et al.
Chest|February 4, 2015
Integration of palliative care in the context of rapid response: a report from the Improving Palliative Care in the ICU advisory boardJudith E Nelson, Kusum S Mathews, David E Weissman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2020
Small-Cell Carcinoma of the Ovary, Hypercalcemic Type-Genetics, New Treatment Targets, and Current Management GuidelinesMarc Tischkowitz, Sidong Huang, Susana Banerjee, et al.
Molecular Cancer Therapeutics|September 21, 2018
Histone Deacetylase Inhibitors Synergize with Catalytic Inhibitors of EZH2 to Exhibit Antitumor Activity in Small Cell Carcinoma of the Ovary, Hypercalcemic TypeYemin Wang, Shary Yuting Chen, Shane Colborne, et al.
Pageof 41

Showing results (381-390 of 408) with videos related to

Sort By:
Pageof 41
The Journal of Pathology|April 27, 2017
The histone methyltransferase EZH2 is a therapeutic target in small cell carcinoma of the ovary, hypercalcaemic typeYemin Wang, Shary Yuting Chen, Anthony N Karnezis, et al.
Genomics|May 8, 1998
Divergently transcribed overlapping genes expressed in liver and kidney and located in the 11p15.5 imprinted domainP R Cooper, N J Smilinich, C D Day, et al.
Oncogene|May 16, 2022
TP53, CDKN2A/P16, and NFE2L2/NRF2 regulate the incidence of pure- and combined-small cell lung cancer in miceSamera H Hamad, Stephanie A Montgomery, Jeremy M Simon, et al.
Oncogene|August 24, 2022
Correction: TP53, CDKN2A/P16, and NFE2L2/NRF2 regulate the incidence of pure- and combined-small cell lung cancer in miceSamera H Hamad, Stephanie A Montgomery, Jeremy M Simon, et al.
Journal of the American Medical Informatics Association : JAMIA|November 18, 2021
Development and validation of a prediction model for actionable aspects of frailty in the text of clinicians' encounter notesJacob A Martin, Andrew Crane-Droesch, Folasade C Lapite, et al.
The Journal of Pathology|July 4, 2020
A conditional mouse expressing an activating mutation in NRF2 displays hyperplasia of the upper gastrointestinal tract and decreased white adipose tissueBrittany M Bowman, Stephanie A Montgomery, Travis P Schrank, et al.
Genomics|November 5, 1997
Functional characterization of human nucleosome assembly protein-2 (NAP1L4) suggests a role as a histone chaperoneP Rodriguez, D Munroe, D Prawitt, et al.
Chest|February 4, 2015
Integration of palliative care in the context of rapid response: a report from the Improving Palliative Care in the ICU advisory boardJudith E Nelson, Kusum S Mathews, David E Weissman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2020
Small-Cell Carcinoma of the Ovary, Hypercalcemic Type-Genetics, New Treatment Targets, and Current Management GuidelinesMarc Tischkowitz, Sidong Huang, Susana Banerjee, et al.
Molecular Cancer Therapeutics|September 21, 2018
Histone Deacetylase Inhibitors Synergize with Catalytic Inhibitors of EZH2 to Exhibit Antitumor Activity in Small Cell Carcinoma of the Ovary, Hypercalcemic TypeYemin Wang, Shary Yuting Chen, Shane Colborne, et al.
Pageof 41